Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 8,976–9,000 of 27,380 studies, newest first · page 360 of 1096.

April 2022 25

  1. 2022-04-11

    Brain MRI Analysis for Alzheimer's Disease Diagnosis Using CNN-Based Feature Extraction and Machine Learning

    ✓ Peer-reviewed Digital health tools Sensors (Basel, Switzerland)

    Key finding: In addition, based on official records, cases of death from Alzheimer's disease have increased significantly. +1 more finding

  2. 2022-04-10

    Roles of physical activity and diet in cognitive aging: is more better?

    ✓ Peer-reviewed Prevention and risk The Clinical neuropsychologist

    Key finding: There was a significant interaction between PASE and MIND on executive functioning and total grey matter volume. +4 more findings

  3. 2022-04-08

    Quantitative Water Permeability Mapping of Blood-Brain-Barrier Dysfunction in Aging

    ✓ Peer-reviewed Vascular contributions Frontiers in aging neuroscience

    Key finding: In this cross-sectional study, we found higher kW values in the cerebral cortex (mean = 81.51 min-1, SD = 15.54) compared to cerebral white matter (mean = 75.19 min-1, SD = 13.85) (p < 0.0001). +3 more findings

  4. 2022-04-08

    Linking circadian rhythms to microbiome-gut-brain axis in aging-associated neurodegenerative diseases

    ✓ Peer-reviewed Disease mechanisms Ageing research reviews

    Key finding: Emerging evidence suggests that both disruption of circadian rhythms and gut dysbiosis are closely related to aging-associated neurodegenerative diseases. +1 more finding

  5. 2022-04-08

    Consideration of sex and gender in Alzheimer's disease and related disorders from a global perspective

    ✓ Peer-reviewed Prevention and risk Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Sex or gender differences in the risk of Alzheimer's disease and related dementias (ADRD) differ by world region, suggesting that there are potentially modifiable risk factors for intervention.

  6. 2022-04-07

    Gut Microbiota Interact With the Brain Through Systemic Chronic Inflammation: Implications on Neuroinflammation, Neurodegeneration, and Aging

    ✓ Peer-reviewed Disease mechanisms Frontiers in immunology

    Key finding: Increasing documentation suggests that the microbiota-gut-brain axis not only impacts brain cognition and psychiatric symptoms but also precipitates neurodegenerative diseases, such as Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis (MS). +2 more findings

  7. 2022-04-07

    Prediction Models for Conversion From Mild Cognitive Impairment to Alzheimer's Disease: A Systematic Review and Meta-Analysis

    ✓ Peer-reviewed Long-term cohort studies Frontiers in aging neuroscience

    Key finding: Alzheimer's disease (AD) is a devastating neurodegenerative disorder with no cure, and available treatments are only able to postpone the progression of the disease. +3 more findings

  8. 2022-04-07

    Early dementia diagnosis, MCI-to-dementia risk prediction, and the role of machine learning methods for feature extraction from integrated biomarkers, in particular for EEG signal analysis

    ✓ Peer-reviewed Digital health tools Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: On clinical data, this innovative approach for early diagnosis might provide more insight into pathophysiological processes underlying degenerative changes, as well as toward a personalized risk evaluation for pharmacological, nonpharmacological, and rehabilitation treatments.

  9. 2022-04-07

    Quantification of amyloid PET for future clinical use: a state-of-the-art review

    ✓ Peer-reviewed Caregiving European journal of nuclear medicine and molecular imaging

    Key finding: The overall load and spatial distribution of brain Aβ can be determined in vivo using positron emission tomography (PET), for which three fluorine-18 labelled radiotracers have been approved for clinical use. +1 more finding

  10. 2022-04-07

    National Coverage Determination: Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease (NCD 200.3)

    ⚠ Regulatory decision — not a study Treatments Centers for Medicare & Medicaid Services

    Key finding: NCD effective April 7, 2022; requires clinical diagnosis of MCI or mild AD dementia with confirmed amyloid pathology +2 more findings

  11. 2022-04-06

    Endothelial BACE1 Impairs Cerebral Small Vessels via Tight Junctions and eNOS

    ✓ Peer-reviewed Vascular contributions Circulation research

    Key finding: We observe a 3.71-fold increase in BACE1 expression in the cerebral microvessels from patients with hypertension. +4 more findings

  12. 2022-04-06

    Repurposing small-molecule drugs for modulating toxic protein aggregates in neurodegenerative diseases

    ✓ Peer-reviewed Drug development Drug discovery today

    Key finding: Taken together, these findings will shed new light on exploiting more repurposed small-molecule drugs targeting different types of toxic proteins to fight NDs in the future.

  13. 2022-04-06

    Assessment of the predictive potential of cognitive scores from retinal images and retinal fundus metadata via deep learning using the CLSA database

    ✓ Peer-reviewed Brain scans and imaging Scientific reports

    Key finding: Metadata alone proved to be more effective in explaining the variance in the sample (20.4%) versus fundus images (9.3%) alone. +1 more finding

  14. 2022-04-06

    Neighborhood disadvantage and dementia incidence in a cohort of Asian American and non‐Latino White older adults in Northern California

    ✓ Peer-reviewed Risk factors Alzheimer s & Dementia

    Key finding: Among non-Latino Whites, ADI was associated with dementia incidence (most vs. least disadvantaged ADI quintile HR = 1.09, 95% confidence interval [CI] = 1.02-1.15). +3 more findings

  15. 2022-04-05

    Oxidative stress: The core pathogenesis and mechanism of Alzheimer's disease

    ✓ Peer-reviewed Disease mechanisms Ageing research reviews

    Key finding: It is a process that causes neuronal damage and occurs in various pathways. +4 more findings

  16. 2022-04-05

    Development of Alzheimer's Disease Biomarkers: From CSF- to Blood-Based Biomarkers

    ✓ Peer-reviewed Biomarkers Biomedicines

    Key finding: In the 115 years since the discovery of Alzheimer's disease (AD), our knowledge, diagnosis, and therapeutics have significantly improved.

  17. 2022-04-05

    Attention-Guided Hybrid Network for Dementia Diagnosis With Structural MR Images

    ✓ Peer-reviewed Long-term cohort studies IEEE transactions on cybernetics

    Key finding: As it is practically challenging to capture local and subtle disease-associated abnormalities directly from the whole-brain sMRI, most of those deep-learning approaches empirically preselect disease-associated sMRI brain regions for model construction. +3 more findings

  18. 2022-04-05

    Reproductive factors and the risk of incident dementia: A cohort study of UK Biobank participants

    ✓ Peer-reviewed Long-term cohort studies PLoS medicine

    Key finding: Women's reproductive factors have been associated with the risk of dementia; however, these findings remain uncertain. +3 more findings

  19. 2022-04-04

    The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer's disease

    ✓ Peer-reviewed Disease mechanisms Molecular therapy : the journal of the American Society of Gene Therapy

    Key finding: Increased ADAM10 activity promoted synaptic plasticity, as revealed by changes in the molecular compositions of synapses and the spine morphology. +1 more finding

  20. 2022-04-04

    Early-stage Alzheimer disease: getting trial-ready

    ✓ Peer-reviewed Treatments Nature reviews. Neurology

    Key finding: A new clinical trials infrastructure is required to increase the efficiency of recruitment and accelerate therapeutic progress. +4 more findings

  21. 2022-04-04

    Astrocytes and oligodendrocytes undergo subtype-specific transcriptional changes in Alzheimer's disease

    ✓ Peer-reviewed Genetics Neuron

    Key finding: To improve understanding of transcriptomic heterogeneity in glia during AD, we used single-nuclei RNA sequencing (snRNA-seq) to characterize astrocytes and oligodendrocytes from apolipoprotein (APOE) Ɛ2/3 human AD and age- and genotype-matched non-symptomatic (NS) brains. +4 more findings

  22. 2022-04-04
  23. 2022-04-04
  24. 2022-04-02
  25. 2022-04-02

    Sleep apnea and the risk of dementia: A systematic review and meta-analysis

    ✓ Peer-reviewed Prevention and risk Journal of Sleep Research

    Key finding: Patients with sleep apnea had an increased risk of developing any type of neurocognitive disorder (HR: 1.43 [95% CI 1.26-1.62]), Alzheimer's disease (HR: 1.28 [95% CI 1.16-1.41]), and Parkinson's disease (HR: 1.54 [95% CI 1.30-1.84]). +4 more findings

Browse the library by subject, with the full score breakdown →